Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 20903 / DOSAGE - CAPSULE;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ribavirin(UNII: 49717AWG6K) (ribavirin - UNII:49717AWG6K) | ribavirin | 40mg in 1 | 200mg | 200mg | 200mg |
Inactive Ingredients
| Ingredient Name | Merck Sharp & Dohme Corp. |
|---|---|
| ALCOHOL(3K9958V90M) | |
| ALUMINUM OXIDE(LMI26O6933) | |
| AMMONIA(5138Q19F1X) | |
| BUTYL ALCOHOL(8PJ61P6TS3) | |
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| GELATIN, UNSPECIFIED(2G86QN327L) | |
| GLYCERIN(PDC6A3C0OX) | |
| ISOPROPYL ALCOHOL(ND2M416302) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |
| PROPYLENE GLYCOL(6DC9Q167V3) | |
| SHELLAC(46N107B71O) | |
| SILICON DIOXIDE(ETJ7Z6XBU4) | |
| SODIUM BENZOATE(OJ245FE5EU) | |
| SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| SORBITOL(506T60A25R) | |
| SUCROSE(C151H8M554) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| WATER(059QF0KO0R) |
